The Role of Alpha Blocker Drugs in Reducing Double J Stent Related Symptoms
DOI:
https://doi.org/10.51253/pafmj.v74i3.6108Keywords:
Alpha blockers, Double J stent, Tamsulosin, Ureteral stent, Ureteric stent symptoms questionnaire.Abstract
Objective: To determine the effect of alpha blocker drugs on reduction of Double J Stent related symptoms.
Study Design: Quasi-experimental study.
Place and Duration of Study: Department of Urology, The Kidney Centre, Post Graduate Training Institute, Karachi Pakistan, from May 2014 to Nov 2019.
Methodology: Total 92 patients who had unilateral stent, inserted retrograde or antegrade, were studied. On 7th postoperative day double J stent related symptoms were documented on Ureteral Stent Symptom Questionnaire and alpha-blocker was started if score is >10. After 4 weeks, data was again collected to assess mean change in Ureteral Stent Symptom Questionnaire score.
Results: Of 92 patients, pre-treatment mean Ureteral Stent Symptom Questionnaire score was 38.36±16.07 and post treatment was 14.87±8.62. Mean difference between pre and post Ureteral Stent Symptom Questionnaire score was found significant (p<0.05).
Conclusion: Administration of Tamsulosin has a positive effect on stent related urinary symptoms and quality of life.
Downloads
References
Goel HK, Kundu AK, Maji TK, Pal DK. Retained fragmented double J ureteric stent: A report of four cases with review of the literature. Saudi J Kidney Dis Transpl 2015; 26(4): 747-750.
https://doi.org/10.4103/1319-2442.160199
Ramachandra M, Mosayyebi A, Carugo D, Somani BK. Strategies to improve patient outcomes and QOL: Current complications of the design and placements of ureteric stents. Res Rep Urol 2020; 12: 303-314.
https://doi.org/10.2147/RRU.S270161
Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Velikanov S, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J 2005; 7(8): 491-494.
Abdelaal AM, Al-Adl AM, Abdelbaki SA, Al Azab MM, Al Gamal KA. Efficacy and safety of tamsulosin oral-controlled absorption system, solifenacin, and combined therapy for the management of ureteric stent-related symptoms. Arab J Urol 2016; 14(2): 115-122. https://doi.org/10.1016/j.aju.2016.02.001
Tahir MM, Seerwan M. Effect of tamsulosin on stent-related symptoms; a prospective study. Prof Med J 2016; 23(1): 106-110.
https://doi.org/10.29309/TPMJ/2016.23.01.343
Campschroer T, Zhu X, Vernooij RW, Lock MT. Alpha‐blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev 2018; 4: CD008509.
https://doi.org/10.1002/14651858.CD008509.pub3
Teama KAH, Abdelsalam AYK, Elmenyawee MEA. Comparative study between tadalafil versus tamsulosin versus halphabarol with terpenes mixture as a medical expulsive therapy for lower ureteric stones. QJM 2020; 113(Supplement_1): hcaa160.005. https://doi.org/10.1093/qjmed/hcaa160.005
He F, Man LB, Li GZ, Liu N. Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison. Drug Des Devel Ther. 2016; 10: 1783-1793. https://doi.org/10.2147/DDDT.S106181
Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG. et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003; 169(3): 1060-1064.
https://doi.org/10.1097/01.ju.0000049203.13140.43
Kwon JK, Cho KS, Oh CK, Kang DH, Lee H, Ham WS, et al. The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo. BMC Urol 2015; 15: 55. https://doi.org/10.1186/s12894-015-0053-8
van der Meer RW, Weltings S, van Erkel AR, Roshani H, Elzevier HW, van Dijk LC, et al. Antegrade ureteral stenting is a good alternative for the retrograde approach. Curr Urol 2016; 10(2): 87-91. https://doi.org/10.1159/000447284
Ahallal Y, Khallouk A, El Fassi MJ, Farih MH. Risk factor analysis and management of ureteral double-j stent complications. Rev Urol 2010; 12(2-3): e147-151. PMID: 20811541.
Leslie SW, Sajjad H. Double J Placement Methods Comparative Analysis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.
Paul CJ, Brooks NA, Ghareeb GM, Tracy CR. Pilot study to determine optimal stent duration following ureteroscopy: three versus seven days. Curr Urol 2017; 11(2): 97-102.
https://doi.org/10.1159/000447284
Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D'Armiento M. et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 2008; 22(4): 651-656. https://doi.org/10.1089/end.2007.0346
Goyal SK, Singh V, Pandey H, Chhabra MK, Aggarwal SP, Bhat A. et al. Comparative efficacy of tamsulosin versus tadalafil as medical expulsive therapy for distal ureteric stones. Urol Ann 2018; 10(1): 82-86. https://doi.org/10.4103/UA.UA_16_17
Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Meta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfort. BJU Int 2011; 108(11): 1894-902.
https://doi.org/10.1111/j.1464-410X.2011.10261.x
Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P. Is there a role for α-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 2011; 186(3): 928-934. https://doi.org/10.1016/j.juro.2011.04.099
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Waqar Ahmed Memon, Ali Haider Khowaja, Salman El Khalid, Asadullah ., Sherjeel Saulat, Jahanzeb Sheikh, Khadijah Abid
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
